These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10443239)

  • 1. [An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].
    Poliakov PIu; Larionova NA; Bychenkov OA; Moc'kin VG
    Vopr Onkol; 1999; 45(3):311-3. PubMed ID: 10443239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
    Moiseenko VM; Blinov NN; Semiglazov VV; Konstantinova MM; Trishkina EA
    Vopr Onkol; 1998; 44(6):725-8. PubMed ID: 10087976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disodium clodronate in the treatment of pain due to bone metastases.
    Luzzani M; Vidili MG; Rissotto R; Nobile MT; Beghè F; Rosso R; Gottlieb A
    Int J Clin Pharmacol Res; 1990; 10(4):243-6. PubMed ID: 2150406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of skeletal disease in breast cancer: a controlled clodronate trial.
    Elomaa I; Blomqvist C; Porkka L; Lamberg-Allardt C; Borgström GH
    Bone; 1987; 8 Suppl 1():S53-6. PubMed ID: 2961355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer and bone metastases. The effect of clodronate.
    Kylmälä T
    Ann Chir Gynaecol; 1998; 87(1):59-60. PubMed ID: 9598233
    [No Abstract]   [Full Text] [Related]  

  • 7. Clodronate for osteolytic metastases due to breast cancer.
    Elomaa I; Blomqvist C; Porkka L; Holmström T; Taube T; Lamberg-Allardt C; Borgström GH
    Biomed Pharmacother; 1988; 42(2):111-6. PubMed ID: 2971403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No value of oral clodronic acid in malignant osteolysis.
    Prescrire Int; 1998 Aug; 7(36):104. PubMed ID: 10342946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future status of adjuvant therapy for breast cancer.
    Coleman RE
    Cancer; 2003 Feb; 97(3 Suppl):880-6. PubMed ID: 12548590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effects of clodronate for the pain treatment of bone metastasis due to prostate cancer].
    Ozyuvaci E; Altan A; Demir C
    Agri; 2005 Jan; 17(1):49-53. PubMed ID: 15791501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of adjuvant clodronate therapy for prevention of bone metastasis in breast cancer].
    Horváth Z
    Magy Onkol; 2002; 46(4):361-4. PubMed ID: 12563361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of Clodronate in the treatment of bone metastasis].
    Pouillart P; Beuzeboc P
    Bull Cancer; 1991; 78(8):737-41. PubMed ID: 1834287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metastatic bone lesions in solid tumors and possible use of clodronate (Bonephos) in clinical oncology].
    Moiseenko VM; Blinov NN
    Vopr Onkol; 1996; 42(2):17-30. PubMed ID: 8815629
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
    Rodrigues P; Hering F; Campagnari JC
    Prostate Cancer Prostatic Dis; 2004; 7(4):350-4. PubMed ID: 15534620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy with disodium clodronate combined with radiotherapy of bone metastasis of solid tumors].
    Botturi M; Zanni D; Tosi G
    Radiol Med; 1990 Nov; 80(5):726-33. PubMed ID: 2148401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clodronate in the management of bone metastases: a clinical study of 91 patients.
    Serkies K; Jereczek-Fossa B; Badzio A; Jassem J
    Neoplasma; 1999; 46(5):317-22. PubMed ID: 10665850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.
    Minutoli F; Herberg A; Spadaro P; Restifo Pecorella G; Baldari S; Aricò D; Altavilla G; Baldari S
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):355-62. PubMed ID: 17043634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial.
    Rosen LS; Gordon D; Kaminski M; Howell A; Belch A; Mackey J; Apffelstaedt J; Hussein M; Coleman RE; Reitsma DJ; Seaman JJ; Chen BL; Ambros Y
    Cancer J; 2001; 7(5):377-87. PubMed ID: 11693896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.